Comments
Loading...

Adaptimmune Therapeutics

ADAPNASDAQ
Logo brought to you by Benzinga Data
$0.586600
-0.0046-0.78%
At close: -
$0.599000
0.012.11%
After Hours: Nov 15, 7:34 PM EDT
Q3 2024 Earnings were released on Wed Nov 13th, after the market close
The most recent conference call was at 16:30 PM, 5 days ago Click to view past webcast

Adaptimmune Therapeutics (NASDAQ:ADAP) Stock, Dividends

Adaptimmune Therapeutics issues dividends to shareholders from excess cash Adaptimmune Therapeutics generates. Most companies pay dividends on a quarterly basis, but dividends may also be paid monthly, annually or at irregular intervals.

Adaptimmune Therapeutics PLC Dividend Overview

Adaptimmune Therapeutics PLC does not currently pay a dividend or dividend information is unavailable.

Adaptimmune Therapeutics PLC's last ex-dividend date and next ex-dividend date are both unknown.

Key Highlights:

  • Annual Payout: -
  • Current Yield: -
  • Next Ex-Dividend Date: Unknown
  • Last Ex-Dividend Date: Unknown
  • Payments per Year: -

Dividends for Adaptimmune Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

When does Adaptimmune Therapeutics (ADAP) pay its next dividend?

A

There are no upcoming dividends for Adaptimmune Therapeutics.

Q

What date did I need to own Adaptimmune Therapeutics (ADAP) stock to get the latest dividend?

A

There are no upcoming dividends for Adaptimmune Therapeutics.

Q

How much per share is the next Adaptimmune Therapeutics (ADAP) dividend?

A

There are no upcoming dividends for Adaptimmune Therapeutics.

Q

What is the dividend yield for Adaptimmune Therapeutics (NASDAQ:ADAP)?

A

There are no upcoming dividends for Adaptimmune Therapeutics.

Q

What was the announcement date for the next Adaptimmune Therapeutics (ADAP) dividend?

A

There are no upcoming dividends announced for Adaptimmune Therapeutics

Q

Why is Adaptimmune Therapeutics (ADAP) dividend considered low?

A

There is not enough data to provide an evaluation.

Q

Is Adaptimmune Therapeutics (ADAP) a good dividend?

A

There is not enough data to provide an evaluation.

Q

Is the Adaptimmune Therapeutics (ADAP) dividend sustainable?

A

There is not enough data to provide an evaluation.

Browse Dividends on all stocks.

People Also Watch